To investigate the phenotypic effects of Nf1 loss in vivo, we used the expression of phosphorylated Erk (p-Erk) as a readout for activation of Ras-mediated Erk/MAPK signaling during early stages of tumor evolution in vivo21,31,32. The gene discussed is NF1; the disease is neoplasm.